XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Statements of Stockholders' (Deficit) Equity (Unaudited) - USD ($)
Series A Convertible Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Note Recievable For Common Stock Related Party [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Apr. 30, 2023   $ 65 $ 62,001,395 $ (14,883,295) $ (44,072,662) $ 3,045,503
Beginning balance, shares at Apr. 30, 2023   646,268        
Issuance of common stock for cash, net of issuance costs   18,087 18,087
Issuance of common stock for cash, net of issuance costs, shares     615        
Issuance of common stock for restricted stock awards  
Issuance of common stock for restricted stock awards, shares     83        
Subscription receivable payment received   (7,002) 7,002
Stock-based compensation to employees and consultants   687,716 687,716
Net loss   (6,433,799) (6,433,799)
Ending balance, value at Oct. 31, 2023   $ 65 62,700,196 (14,876,293) (50,506,461) (2,682,493)
Ending balance, shares at Oct. 31, 2023   646,966        
Beginning balance, value at Jul. 31, 2023   $ 65 62,370,775 (14,883,295) (47,600,428) (112,883)
Beginning balance, shares at Jul. 31, 2023   646,268        
Issuance of common stock for cash, net of issuance costs   18,087 18,087
Issuance of common stock for cash, net of issuance costs, shares     615        
Issuance of common stock for restricted stock awards  
Issuance of common stock for restricted stock awards, shares     83        
Subscription receivable payment received   (7,002) 7,002
Stock-based compensation to employees and consultants   318,336 318,336
Net loss   (2,906,033) (2,906,033)
Ending balance, value at Oct. 31, 2023   $ 65 62,700,196 (14,876,293) (50,506,461) (2,682,493)
Ending balance, shares at Oct. 31, 2023   646,966        
Beginning balance, value at Apr. 30, 2024 $ 69 51,426,154   (54,020,408) (2,594,185)
Beginning balance, shares at Apr. 30, 2024 2,100 687,999        
Issuance of common stock for cash, net of issuance costs $ 76 1,174,148   1,174,224
Issuance of common stock for cash, net of issuance costs, shares     755,888        
Issuance of common stock for restricted stock awards  
Issuance of common stock for restricted stock awards, shares     83        
Issuance of preferred stock for cash, net of issuance costs 7,088,644   7,088,644
Issuance of preferred stock for cash, net of issuance costs, shares 800            
Conversion of preferred stock to common stock $ 378 (378)  
Conversion of preferred stock to common stock, shares (712)   3,787,284        
Conversion of note payable and interest to preferred stock 311,356   311,356
Stock-based compensation to employees and consultants 162,554   162,554
Net loss   (2,389,625) (2,389,625)
Ending balance, value at Oct. 31, 2024 $ 523 60,162,478 (56,410,033) 3,752,968
Ending balance, shares at Oct. 31, 2024 88 2,100 5,231,254        
Beginning balance, value at Jul. 31, 2024 $ 86 53,782,414 (54,994,819) (1,212,319)
Beginning balance, shares at Jul. 31, 2024 188 2,100 861,332        
Issuance of common stock for cash, net of issuance costs $ 76 1,174,148   1,174,224
Issuance of common stock for cash, net of issuance costs, shares     755,888        
Issuance of common stock for restricted stock awards  
Issuance of common stock for restricted stock awards, shares     83        
Issuance of preferred stock for cash, net of issuance costs 5,125,000   5,125,000
Issuance of preferred stock for cash, net of issuance costs, shares 550            
Conversion of preferred stock to common stock $ 361 (361)  
Conversion of preferred stock to common stock, shares (650)   3,613,951        
Stock-based compensation to employees and consultants 81,277   81,277
Net loss (1,415,214) (1,415,214)
Ending balance, value at Oct. 31, 2024 $ 523 $ 60,162,478 $ (56,410,033) $ 3,752,968
Ending balance, shares at Oct. 31, 2024 88 2,100 5,231,254